Virginia Regulatory Town Hall
Department of Health Professions
Board of Optometry
Regulations of the Virginia Board of Optometry [18 VAC 105 ‑ 20]
Action is Exempt from Article 2 of the Administrative Process Act
Addition of alpha-adrenergic agonists to TPA formulary
Action 5622
General Information
Action Summary The Board is amending 18VAC105-20-47 to add alpha-adrenergic agonists to the TPA formulary in the category of a Schedule VI topically administered medication.
Chapters Affected Only affects this chapter.
Executive Branch Review This Action is exempt from Article 2 of the Administrative Process Act. The normal executive branch review process is not required. As such, it can be submitted directly for publication and is effective upon publication.
Exempt Citation: ยง 2.2-4002(14)
RIS Project Yes  [006523]
New Periodic Review This action will not be used to conduct a new periodic review.
Stages associated with this regulatory action.
Stage ID Stage Type Status
9092 Proposed Stage complete. No comment period held.
9112 Final Stage complete. This regulation became effective on 12/09/2020.
Contact Information
Name / Title: Leslie L. Knachel  / Executive Director
Address: 9960 Mayland Drive
Suite 300
Henrico, VA 23233
Email Address:
Phone: (804)597-4130    FAX: (804)793-9145    TDD: ()-

This person is the primary contact for this board.